Pre-radiotherapy feeding tube identifies a poor prognostic subset of postoperative p16 positive oropharyngeal carcinoma patients

Radiation Oncology

Volumn 10, Issue 1, 2015, Pages

  Verma, Vivek ^a   Liu, Jingxia ^b   Eschen, Laura ^b   Danieley, Jonathan ^b   Spencer, Christopher ^b   Lewis, James S ^b   Diaz, Jason ^b   Piccirillo, Jay F ^b   Adkins, Douglas R ^b   Nussenbaum, Brian ^b   Thorstad, Wade L ^b   Gay, Hiram A ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant intensity modulated radiation therapy; Definitive surgery; Human papillomavirus; Oropharynx squamous cell carcinoma; p16 positive; PEG feeding tube

Indexed keywords

CETUXIMAB; CISPLATIN; PROTEIN P16; P16 PROTEIN, HUMAN; TUMOR PROTEIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; COMORBIDITY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; FEEDING APPARATUS; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MICROSURGERY; OPERATION DURATION; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; POSTOPERATIVE PERIOD; SMOKING; ADJUVANT RADIOTHERAPY; CARCINOMA, SQUAMOUS CELL; ENTERIC FEEDING; ENZYME IMMUNOASSAY; METABOLISM; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; OROPHARYNGEAL NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ENTERAL NUTRITION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; POSTOPERATIVE PERIOD; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; SURVIVAL RATE;

EID: 84924259700     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/s13014-014-0314-3     Document Type: Article

References (17)

1. Pezner RD, Archambeau JO, Lipsett JA, Kokal WA, Thayer W, Hill LR. Tube feeding enteral nutritional support in patients receiving radiation therapy for advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1987;13(6):935-9.
2. Koyfman SA, Adelstein DJ. Enteral feeding tubes in patients undergoing definitive chemoradiation therapy for head-and-neck cancer: a critical review. Int J Radiat Oncol Biol Phys. 2012;84(3):581-9.
3. Corry J, Poon W, McPhee N, Milner AD, Cruickshank D, Porceddu SV, et al. Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation. Head Neck. 2009;31(7):867-76.
4. Wiggenraad RG, Flierman L, Goossens A, Brand R, Verschuur HP, Croll GA, et al. Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study. Clin Otolaryngol. 2007;32(5):384-90.
5. Silander E, Nyman J, Bove M, Johansson L, Larsson S, Hammerlid E. Impact of prophylactic percutaneous endoscopic gastrostomy on malnutrition and quality of life in patients with head and neck cancer: a randomized study. Head Neck. 2012;34(1):1-9.
6. Cady J. Nutritional support during radiotherapy for head and neck cancer: the role of prophylactic feeding tube placement. Clin J Oncol Nurs. 2007;11(6):875-80.
7. Madhoun MF, Blankenship MM, Blankenship DM, Krempl GA, Tierney WM. Prophylactic PEG placement in head and neck cancer: how many feeding tubes are unused (and unnecessary)? World J Gastroenterol. 2011;17(8):1004-8.
8. McLaughlin BT, Gokhale AS, Shuai Y, Diacopoulos J, Carrau R, Heron DE, et al. Management of patients treated with chemoradiotherapy for head and neck cancer without prophylactic feeding tubes: the University of Pittsburgh experience. Laryngoscope. 2010;120(1):71-5.
9. Lewis Jr JS, Chernock RD, Ma XJ, Flanagan JJ, Luo Y, Gao G, et al. Partial p16 staining in oropharyngeal squamous cell carcinoma: extent and pattern correlate with human papillomavirus RNA status. Mod Pathol. 2012;25(9):1212-20.
10. Steiner W, Ambrosch P. Endoscopic Laser Surgery of the Uper Aerodigestive Tract: with Special Emphasis on Cancer Surgery. New York: Thieme Medical Publishers; 2000.
11. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24-35.
12. Daly ME, Le QT, Maxim PG, Loo Jr BW, Kaplan MJ, Fischbein NJ, et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys. 2010;76(5):1339-46.
13. Setton J, Caria N, Romanyshyn J, Koutcher L, Wolden SL, Zelefsky MJ, et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys. 2012;82(1):291-8.
14. Bhayani MK, Hutcheson KA, Barringer DA, Lisec A, Alvarez CP, Roberts DB, et al. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence. Head Neck. 2013;35(11):1634-40.
15. Rosenthal DI, Liu L, Lee JH, Vapiwala N, Chalian AA, Weinstein GS, et al. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck. 2002;24(2):115-26.
16. Huang K, Xia P, Chuang C, Weinberg V, Glastonbury CM, Eisele DW, et al. Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience. Cancer. 2008;113(3):497-507.
17. Yao M, Nguyen T, Buatti JM, Dornfeld KJ, Tan H, Wacha J, et al. Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research. Am J Clin Oncol. 2006;29(6):606-12.